Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6826222 | Schizophrenia Research | 2013 | 4 Pages |
Abstract
To examine the effect of prolactin-raising antipsychotics on bone mineral density (BMD), data of 164 schizophrenia patients who received â¥Â 2 dual-energy x-ray absorptiometry scans were analyzed (49.3% men; mean ± SD age: 58.5 ± 11.0 years; duration of treatment: 26.7 ± 13.8 years). Patients were divided into a prolactin-raising antipsychotic (n = 141) or prolactin-sparing (n = 23) group, and time x group interaction was examined using mixed effect model. Although the BMD difference did not reach significance over 3.4 ± 1.6 years, a significant antipsychotic-class vs. time interaction was found (p = 0.011), indicating a negative impact of prolactin-raising antipsychotics on BMD. Large-scale, randomized-controlled data are required to replicate and extend these findings.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Tatsuichiro Takahashi, Hiroyuki Uchida, Majnu John, Jinichi Hirano, Koichiro Watanabe, Masaru Mimura, Christoph U. Correll, Taishiro Kishimoto,